3 takeaways from TCT 2026

Edwards' TAVR results in moderate aortic stenosis, Medtronic's renal denervation, and Abbott's left atrial appendage closure devices all produced positive study findings at the TCT conference. These represent significant advances in cardiac device technology and clinical outcomes.